Stay updated on Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.

Latest updates to the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page
- Check2 days agoChange DetectedAdded Mesangiocapillary glomerulonephritis, type II to the list of conditions.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Complement 3 glomerulopathy as a condition and removed Non-immunoglobulin-mediated membranoproliferative glomerulonephritis.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision note updated to v3.5.0; the v3.4.3 reference was removed.SummaryDifference0.0%

- Check24 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded the term Non-immunoglobulin-mediated membranoproliferative glomerulonephritis under the conditions and a Resources section linking Genetic and Rare Diseases Information Center; the page revision was updated to v3.4.2. Removed the government funding notice and the prior revision note v3.4.1.SummaryDifference0.5%

- Check59 days agoChange DetectedAdded a global notice about potential delays due to a lapse in government funding. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.